| 摘要 |
<p>The present invention is based on the discovery of a novel bimolecular, bi-directional mechanism of regulation between nm23 and Rad. Accordingly, the present invention provides a method of modulating an activity of nm23 in a subject at risk for a proliferative disorder, comprising: modulating the level of Rad activity.</p> |
